Women with low-grade abnormalities on Pap smear should be referred for colposcopy

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 44, Issue 3, 2004, Pages 252-255

  Fairman, Amanda ^a   Tan, Jeffrey ^a   Quinn, Michael ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Colposcopy; Consumer; Pap smear

Indexed keywords

ARTICLE; COLPOSCOPY; CONSUMER; DATA BASE; DIAGNOSTIC APPROACH ROUTE; FEMALE; HUMAN; MEDICOLEGAL ASPECT; PAPANICOLAOU TEST; PATIENT REFERRAL; PRIORITY JOURNAL; TEACHING HOSPITAL; TUMOR GROWTH; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX TUMOR;

BIOPSY; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPES; FEMALE; HUMANS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 3242762323     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2004.00223.x     Document Type: Article

References (31)

1. Solomon D, Davey D, Kurman R et al. The Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002; 287: 2114-2119.
2. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002; 287: 2120-2129.
3. Nasiel K, Roger V, Nasiel M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynaecol. 1986; 67: 665-669.
4. Carmichael JA, Maskens PD. Cervical dysplasia and human papillomavirus. Am J Obstet Gynaecol. 1989; 160: 916-918.
5. Soutter WP, Wisdom S, Brough AK, Monaghan JM. Should patients with mild atypia in a cervical smear be referred for colposcopy? Br J Obstet Gynaecol. 1986; 93: 70-74.
6. Walker EM, Dodgson J, Duncan ID. Does mild atypia on a cervical smear warrant further investigation? Lancet. 1986; 2: 672-673.
7. Hall S, Wu TC, Soudi N, Sherman ME. Low-grade squamous intraepithelial lesions: Cytologic predictors of biopsy confirmation. Diagn Cytopathol. 1994; 10: 3-9.
8. Lonky NM, Navarre GL, Saunders S, Sadeghi M, Wolde-Tsadik G. Low-grade Papanicolaou smears and the Bethesda system: a prospective cytohistopathologic analysis. Obstet Gynaecol. 1995; 85: 716-720.
9. Lee KR, Minter LJ, Crum CP. Koilocytotic atypia in Papanicolaou smears: Reproducibility and biopsy correlates. Cancer Cytopathol. 1997; 81: 10-15.
10. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA. 1994; 271: 1866-1869.
11. Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynaecol. 1998; 91: 973-976.
12. Law KS, Chang TC, Hsueh S, Jung SM, Tseng CJ, Lai CH. High prevalence of high grade squamous intraepithelial lesions and microinvasive carcinoma in women with a cytologic diagnosis of low grade squamous intraepithelial lesions. J Reprod Med. 2001; 46: 61-64.
13. Jones BA, Novis DA. Follow-up of abnormal gynaecologic cytology: a college of American pathologists Q-probes study of 16132 cases from 306 laboratories. Arch Pathol Lab Med. 2000; 124: 665-671.
14. Lonky NM, Sadeghi M, Tsadik GW, Petitti D. The clinical significance of the poor correlation between dysplasia and cervical malignancy with referral cytologic results. Am J Obstet Gynaecol. 1999; 181: 560-566.
15. Kirby AJ, Spiegelhalter DJ, Day NE et al. Conservative treatment of mild/moderate dyskaryosis: long-term outcome. Lancet. 1992; 339: 828-831.
16. Robertson JJ, Woodend BE, Crozier EH, Hutchinson J. Risk of cervical cancer associated with mild dyskaryosis. BMJ. 1988; 297: 18-21.
17. Van Wijngaarden WJ, Duncan ID. Upper age limit for cervical screening. BAJ. 1993; 306: 356-360.
18. Fletcher A, Soutter WP. Cytological surveillance for mild cervical dyskaryosis. Lancet. 1992; 340: 553.
19. Valmadre S, Atkinson K, Houghton R et al. High grade abnormalities following an inconclusive smear. Aust NZ J Obstet Gynaecol. 2002; 42: 391-394.
20. Schoolland M, Sterrett GF, Knowles SA, Mitchell KM, Kurinczuk JJ. The 'inconclusive - possible high grade epithelial abnormality' category in Papanicolaou smear reporting. Cancer. 1998; 84: 208-217.
21. Gustafsson L, Sparen P, Gustafsson M, Wilander E, Bergstrom R, Adami HO. Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix. Br J Cancer. 1995; 72: 498-505.
22. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet. 1987; 1: 1247-1249.
23. Anderson GH, Benedet JL, Le Riche JC, Matisic JP, Thompson JE. Invasive cancer of the cervix in British Columbia: a review of the demography and screening histories of 437 cases seen from 1988-1988. Obstet Gynaecol. 1992; 80: 1-4.
24. Patnick J. Cervical cancer screening in England. Eur J Cancer. 2000; 36: 2205-2208.
25. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 1995; 172: 946-954.
26. Wright TC, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low grade cytologic abnormalities. Obstet Gynaecol. 1995; 85: 716-720.
27. Ferenczy A, Franco E, Arseneau J, Wright TC, Richart RM. Diagnostic performance of hybrid capture human papillomavirus deoxyribonucleic acid assay combined with liquid based cytologic study. Am J Obstet Gynecol. 1996; 175: 651-656.
28. Sherman ME, Schiffman MH, Lorincz AT et al. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Cancer. 1997; 81: 89-97.
29. Dudding N, Sutton J, Lane S. Koilocytosis; an indication for conservative management. Cytopathology. 1996; 7: 32-37.
30. Hirschowitz L, Raffle AE, Mackenzie EF, Hughes AO. Long term follow up of women with borderline cervical smear test results: effects of age and viral infection on progression to high grade dyskaryosis. BMJ. 1992; 304: 1209-1212.
31. Sherman ME, Soloman D, Schiffman M. Qualification of ASCUS: a comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study (ALTS). Am J Clin Pathol. 2001; 116: 386-394.